Skip to Main Content

Paper Details

Leveraging extrachromosomal DNA to fine-tune trials of targeted therapy for glioblastoma: opportunities and challenges.
Nat Rev Clin Oncol
9
2022
Author NameAffiliation
Paul S MischelStanford University School of Medicine and Sarafan ChEM-H, Stanford University
Charles SwantonThe Francis Crick Institute
  • 1 - 2

Datasets

Release 1.2